- Home
- SLS vs OMI Comparison
SLS vs OMI Comparison
Compare SLS & OMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLS | OMI |
|---|---|---|
| Founded | 2012 | 1882 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.0M | 228.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SLS | OMI |
|---|---|---|
| Price | $2.85 | $2.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 6 |
| Target Price | ★ $7.00 | $6.46 |
| AVG Volume (30 Days) | ★ 6.1M | 1.9M |
| Earning Date | 11-12-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $10,768,859,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 132.03 |
| 52 Week Low | $0.85 | $2.38 |
| 52 Week High | $3.00 | $15.54 |
Technical Indicators
Market Signals| Indicator | SLS | OMI |
|---|---|---|
| Relative Strength Index (RSI) | 81.83 | 40.13 |
| Support Level | $1.92 | $2.60 |
| Resistance Level | $2.31 | $3.28 |
| Average True Range (ATR) | 0.20 | 0.19 |
| MACD | 0.10 | 0.04 |
| Stochastic Oscillator | 88.51 | 36.67 |
Price Performance
Historical ComparisonAbout SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.